)
)
)
Athos Therapeutics Inc.
Athos: an AI software & clinical stage biotechnology company developing first-in-class therapeutics to significantly impact patients with autoimmune and inflammatory diseases.
The Athos drug development platform begins with 35,000 high-quality patient samples sourced from premier global hospitals.
Athos lead drug compound, ATH-063, a first-in-class oral small molecule for inflammatory bowel disease soon to enter a Phase 2 clinical trial.
Athos is also developing a pipeline of additional small molecule approaches for various autoimmune diseases.
The AthosOmics.AI platform identifies novel drug/protein targets by integration of multi-omic and longitudinal clinical datasets from patients.
The software is a novel one-stop solution, from raw patient data to drug development.
It successfully predicted the MoA of ATH-063 years before human clinical trials and is driving the drug asset pipeline of Athos.
The platform provides no-code solutions for any industry working with omics data.
Address
TorranceCA
United States
)
){kind=logo}
)
){kind=logo}
){kind=logo}
)
)
)
)